<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding the therapeutic potential of the seven potent SARS-CoV-2 3CLpro inhibitors, dose–response curves of ethacrynic acid, naproxen, allopurinol, butenafine hydrochloride, raloxifene hydrochloride, tranylcypromine hydrochloride and saquinavir mesylate are shown in 
 <xref ref-type="fig" rid="F0002">Figure 2</xref>, with their IC
 <sub>50</sub> values and chemical structures. The measured IC
 <sub>50</sub> values were 1.11 ± 0.11, 3.45 ± 0.49, 3.77 ± 0.62, 5.40 ± 0.78, 5.61 ± 0.23, 8.64 ± 3.17, and 9.92 ± 0.73 µM, respectively. Interestingly, despite the different protease family, saquinavir mesylate, an inhibitor of aspartate proteases
 <xref rid="CIT0017" ref-type="bibr">
  <sup>17</sup>
 </xref>, was able to inhibit SARS-CoV-2 3CLpro, a cysteine protease.
</p>
